Twist Bioscience Spin-Out and Q2 2025 Financial Results

Details

The company also announced the spin-out of its DNA data storage application as an independent company, Atlas Data Storage, funded by $155M from strategic investors. The spin-out is expected to accelerate DNA data storage development while allowing Twist to focus on profitability. The company expects full-year revenue between $372M and $379M with a gross margin over 50% for the fourth quarter.

Items reported

Exhibits (2)

About Twist Bioscience Corporation

Twist Bioscience Corporation is a synthetic biology company that develops and sells DNA-based products for research and commercial applications. Twist Bioscience Corporation’s portfolio includes synthetic genes, gene fragments, oligonucleotide pools, and antibody libraries used in therapeutic discovery, diagnostics, agriculture, industrial biotechnology, and academic research. The company also supports advanced workflows such as targeted next-generation sequencing, CRISPR gene editing, mutagenesis, and DNA data storage. Its proprietary semiconductor-based DNA synthesis platform is designed to produce high-quality synthetic DNA at scale, helping customers move from design to experimentation more efficiently. Twist Bioscience Corporation serves biotechnology, pharmaceutical, industrial, and academic customers across multiple regions, making it an important supplier in the life sciences tools and synthetic biology market.